Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival

Asia-Pacific Journal of Clinical Oncology

Volumn 8, Issue 3, 2012, Pages

  Zhou, Jian ^a,b   Li, Jie ^b   Wang, Zengjun ^b   Yin, Changjun ^b   Zhang, Wei ^b  

^a Department of Urology   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Immunohistochemical staining; Ki67; MTDH; Pathology

Indexed keywords

KI 67 ANTIGEN; METADHERIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CLASSIFICATION; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UNION FOR INTERNATIONAL CANCER CONTROL STAGE; WORLD HEALTH ORGANIZATION CLASSIFICATION;

CELL ADHESION MOLECULES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; NEOPLASM GRADING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84865435507     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2012.01541.x     Document Type: Article

References (17)

1. Lynch CF, Davla JA, Platz CE. Cancer of the urinary bladder 1-12. SEER Survival Monograph, National Cancer Institute; 181-92. SEER database. Available from: http://seer.cancer.gov/publications/survival/surv_bladder.pdf (Accessed 8 March 2012).
2. Proctor I, Stoeber K, Williams GH. Biomarkers in bladder cancer. Histopathology 2010; 57: 1-13.
3. Dey P. Urinary markers of bladder carcinoma. Clin Chim Acta 2004; 340: 57-65.
4. van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 2005; 47: 736-48.
5. Lee SG, Su ZZ, Emdad L etal. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 2006; 14: 17390-5.
6. Hu G, Chong RA, Yang Q etal. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor prognosis breast cancer. Cancer Cell 2009; 15: 9-20.
7. Li J, Zhang N, Song LB etal. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008; 14: 3319-26.
8. Yu C, Chen K, Zheng H etal. Overexpression of astrocyte elevated gene-1 (aeg-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009; 30: 894-901.
9. Liu H, Song X, Liu C etal. Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemosensitivity to cisplatin or doxorubicin in neuroblastoma cells. J Exp Clin Cancer Res 2009; 28: 19-28.
10. Kikuno N, Shiina H, Urakami S etal. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007; 26: 7647-55.
11. Brown DM, Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004; 5: 365-74.
12. Yoo BK, Emdad L, Su ZZ etal. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 2009; 119: 465-77.
13. Valera V, Yokoyama N, Walter B etal. Clinical significance of Ki-67 proliferation index in disease progression and prognosis of patients with resected colorectal carcinoma. Br J Surg 2005; 92: 1002-7.
14. Salminen E, Palmu S, Vahlberg T etal. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. World J Gastroenterol 2005; 11: 3245-9.
15. Liukkonen T, Rajala P, Raitanen M, Rintala E, Kaasinen E, Lipponen P. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa / T1) bladder cancer: a prospective comparative study. Eur Urol 1999; 36: 393-400.
16. Pfister C, Lacombe L, Vezina MC etal. Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors. Hum Pathol 1999; 30: 1350-5.
17. Wu TT, Chen JH, Lee YH, Huang JK. The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma. J Urol 2000; 163: 758-60.